HCM Learning Series 4.0 Part 4: Advancing Care in HCM: Evidence-Based Strategies for Management and Case-Based Insights
The CCS is pleased to present the fourth and final part of the Hypertrophic Cardiomyopathy Learning Series 4.0. Join leading experts for an in-depth and practical discussion on optimizing care for patients with hypertrophic cardiomyopathy (HCM). This interactive session will review the latest clinical evidence and emerging therapies for obstructive HCM, highlight strategies for managing complex cases through a multidisciplinary lens, and address comprehensive care considerations in HCM—including symptom management, microvascular angina, and sex-specific factors. Through concise updates and real-world case discussions, faculty will provide actionable insights to support evidence-based decision-making and improved patient outcomes.
Tailored to address the distinct healthcare challenges within each region, the series consists of four parts that cover: Atlantic Canada (Part 1), Quebec (Part 2), Ontario (Part 3), and Western Canada (Part 4). This session (Part 4) focuses on Western Canada and is designed to address regional challenges in diagnosing and managing HCM through practical, case-based learning.
Do you have a complex or challenging case that could spark meaningful discussion? We invite you to submit it for consideration. Selected cases will be featured during one of our four sessions. Click here to submit your cases.
Date: December 10, 2025 from 5:00 p.m. to 6:00 p.m. PT (8:00 p.m. to 9:00 p.m. ET)
Program Chair and Moderator: Dr. Anil Gupta
Presenters: Dr. Kevin Ong, Dr. Tara Sedlak
Registration
Registration is closed.